Rising serum levels of CA19-9, CRP and ALP were apparent in BTC cases towards diagnosis, and all 3 markers were significantly (P < 0.05) different between BTC and non-cancer controls up to two years before diagnosis. This evidence concerns the gene CRP and cancer.